At 2.8% of CAGR Sarcoma Biopsy Market Share Touch US$ 247.47 Million by the End of 2027 | Latest CMI
) , by End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 192.55 million in 2019, and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Global sarcoma biopsy market is expected to witness to significant growth during the forecast period, owing to increasing technological advancements in the field of biopsy. For instance, in November 2015, Cook Medical launch...
Source: pharmiweb.com